Laurence Gouzi Abrami

Official source

https://people.epfl.ch/laurence.abrami

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

About
Privacy
Disclaimer

Graph Chatbot

Official source

https://people.epfl.ch/laurence.abrami

About this result

Related units (1)

Related publications (29)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

Related units (1)

Prof. van der Goot Group

EPFL
SV
GHI
VDG

Related publications (29)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

Pou5f1b inhibitors

Didier Trono, Françoise Gisou van der Goot Grunberg, Laurence Gouzi Abrami, Sandra Eloise Kjeldsen, Laia Simo Riudalbas

The invention provides an agent modulating the expression and/or activity of i) the POU5F1B protein, a fragment or variant thereof, ii) an mRNA encoding POU5F1B, a fragment or variant thereof and/or iii) the POU5F1B gene. Preferably, the agent is for use i ...

2024

Mechanisms and functions of protein S-acylation

Françoise Gisou van der Goot Grunberg, Laurence Gouzi Abrami, Francisco De Magalhães Sarmento R De Mesquita

Over the past two decades, protein S-acylation (often referred to as S-palmitoylation) has emerged as an important regulator of vital signalling pathways. S-Acylation is a reversible post-translational modification that involves the attachment of a fatty a ...

Nature Portfolio2024

Laurence Gouzi Abrami

Graph Chatbot

Pou5f1b inhibitors

Mechanisms and functions of protein S-acylation

ER-Golgi membrane contact sites control the formation of plasma membrane lipid nanodomains

Pou5f1b inhibitors

Mechanisms and functions of protein S-acylation

ER-Golgi membrane contact sites control the formation of plasma membrane lipid nanodomains